JAY T FLATLEY Insider Trading $JUNO Juno Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JAY T FLATLEY.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JAY T FLATLEY. JAY T FLATLEY is Director in COHERENT INC ($COHR) and Chief Executive Officer in ILLUMINA INC ($ILMN) and Director in ILLUMINA INC ($ILMN) and President & CEO in ILLUMINA INC ($ILMN) and President & CEO Officer in ILLUMINA INC ($ILMN) and President and CEO in ILLUMINA INC ($ILMN) and Director in Juno Therapeutics, Inc. ($JUNO) and in Zymergen Inc. ($ZY) and Director in Denali Therapeutics Inc. ($DNLI).
JAY T FLATLEY in Juno Therapeutics, Inc.
Trading Symbol: JUNOIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of JAY T FLATLEY: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Mar 07 2018
$JUNO Market Capitalization: $2.09B
$JUNO Previous Close: $20.76
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of JAY T FLATLEY in Juno Therapeutics, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, COHR, DNLI, ILMN, JUNO, ZY
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 07 2018 | JUNO | Juno Therapeutics, ... | FLATLEY JAY T | Director | Option Exercise | D | 23.29 | 12,000 | 279,480 | 0 | |
Mar 07 2018 | JUNO | Juno Therapeutics, ... | FLATLEY JAY T | Director | Option Exercise | D | 24.07 | 18,000 | 433,260 | 0 | |
Mar 07 2018 | JUNO | Juno Therapeutics, ... | FLATLEY JAY T | Director | Sell | U | 87.00 | 31,500 | 2,740,500 | 0 | 31.5 K to 0 (-100.00 %) |
Jan 30 2018 | JUNO | Juno Therapeutics, ... | FLATLEY JAY T | Director | Buy | P | 22.92 | 10,000 | 229,200 | 31,500 | 21.5 K to 31.5 K (+46.51 %) |
Jun 19 2017 | JUNO | Juno Therapeutics, ... | FLATLEY JAY T | Director | Option Exercise | A | 23.29 | 12,000 | 279,480 | 12,000 | |
May 26 2017 | JUNO | Juno Therapeutics, ... | FLATLEY JAY T | Director | Buy | P | 24.37 | 10,000 | 243,700 | 21,500 | 11.5 K to 21.5 K (+86.96 %) |
May 26 2017 | JUNO | Juno Therapeutics, ... | FLATLEY JAY T | Director | Buy | P | 25.15 | 10,000 | 251,517 | 11,500 | 1.5 K to 11.5 K (+666.67 %) |
May 23 2017 | JUNO | Juno Therapeutics, ... | FLATLEY JAY T | Director | Option Exercise | A | 24.07 | 18,000 | 433,260 | 18,000 |
Page: 1